Hair loss has frustrated millions of men worldwide for decades, with few truly novel treatments emerging beyond minoxidil and oral anti-androgens. But 2025 may mark a turning point. A company-backed ...
Dr. Hordinsky discusses how clascoterone 5% topical solution may reshape male AGA management and expand treatment confidence.
Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia December 11, 2025 10:00 AM ESTCompany ...
Absci Corporation stock jumps after initiating dosing in its phase I/IIa ABS-201 study for androgenetic alopecia, seeking early safety and efficacy signals.
Study to evaluate safety and efficacy of novel anti-PRLR antibody; interim data anticipated in the second half of 2026Trial design leverages ...
Cosmo Pharmaceuticals has revealed topline results from two phase 3 trials which indicate that its topical cream clascoterone ...
Texas has a hair loss prescription fill rate of 0.74%, which is higher than the national average of 0.7% and ranks as the #15 ...
An acne drug, clascoterone, has demonstrated remarkable results in treating male pattern baldness. In two large Phase III ...
15don MSN
Your favourite soda could be silently causing hair loss and thinning: How sugar harms hair follicles
New research links high consumption of sugary sodas to increased hair fall, particularly in young adults. Studies indicate that excessive sugar intake can trigger hormonal imbalances, inflammation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback